Document is current
Any future updates will be listed below
-
Authors
Chen, Shuying https://orcid.org/0000-0001-8174-704X
Huang, Xiangang https://orcid.org/0000-0001-8948-7879
Xue, Yonger https://orcid.org/0000-0002-6022-2487
Álvarez-Benedicto, Ester https://orcid.org/0000-0002-6405-7650
Shi, Yesi
Chen, Wei
Koo, Seyoung
Siegwart, Daniel J. https://orcid.org/0000-0003-3823-1931
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
- License Information
-
More Information
Article History
Accepted: 28 June 2023
First Online: 17 August 2023
Competing interests
: D.J.S. declares the following competing interests: ReCode Therapeutics, Tome Biosciences, Signify Bio, and Pfizer Inc. Y.D. is a scientific advisory board member of Oncorus Inc., Arbor Biotechnologies, and FL85. The other authors declare no competing interests.
